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INTRODUCTION
Infl ammation is induced by physical or noxious chemical stimuli or microbiological toxins as the normal response of living tissue. It is well known that chronic infl ammation can cause infl ammatory diseases, such as arthritis, asthma, multiple sclerosis, infl ammatory bowel disease, and atherosclerosis (Shin et al., 2010) . Macrophages are activated by various factors such as pro-infl ammatory cytokines, bacterial lipopolysaccharide (LPS), and phorbol esters. Activated macrophages produce many cytokines, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β), and other infl ammatory mediators such as nitric oxide (NO) and prostaglandin E 2 (PGE 2 ) (Reddy and Reddanna, 2009) . NO is a free radical produced by nitric oxide synthase (NOS), which exists as three NOS isoforms: endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS). Macrophages after LPS stimulation produce NO by up-regulating iNOS expression through mitogen-activated protein kinases (MAPK) and NF-κB signaling pathways (Pansanit et al., 2013) . In response to macrophage activation, LPS stimulates a Toll-like receptor 4 (TLR4)-mediated myeloid differentiation factor (MyD88)-dependent pathway, which in turn activates the transforming growth factor-β-activated protein kinase 1 (TAK1), which subsequently results in activation of nuclear factor-κB (NF-κB) and activating protein-1 (AP-1), and produces infl ammatory cytokines including TNF-α, IL-6, and IL-1β (Kawai and Akira, 2006) . Therefore, inhibition of these infl ammatory mediators has been considered as an effective strategy for the development of anti-infl ammatory drugs (Shin et al., 2010; Pansanit et al., 2013) .
Mangosteen (Garcinia mangostana) is a tropical tree from Southeast Asia including Malaysia, India, Myanmar, Philippines, and Thailand. The seedcases of mangosteen-fruit have been traditionally used for treating skin infections and wounds
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Biomol Ther 22(4), 288-294 (2014) www.biomolther.org for centuries by Southeast Asians. It is also used to treat infl ammation, diarrhea, cholera, and dysentery in Ayurvedic medicine (Pedraza-Chaverri et al., 2008) . Phytochemical studies have shown that G. mangostana contains a variety of secondary metabolites such as oxygenated and prenylated xanthones (Suksamrarn et al., 2002) . These xanthone compounds have been reported to indicate various biological activities such as antioxidant, antitumor, anti-infl ammatory, antiallergy, antibacterial, antifungal, antiviral, and antimalarial properties (Suksamrarn et al., 2002; Pedraza-Chaverri et al., 2008) . A recent study documented that 12 xanthones including new xanthone mangostenone F (MF) isolated from the seedcases of G. mangostana indicate neuraminidase inhibitory activity (Ryu et al., 2010) . It has also been reported that mangosteen's xanthones including MF indicate α-glucosidase inhibition and antihyperglycemic activity (Ryu et al., 2011) . In addition, it has been demonstrated that MF from the seedcases of G. mangostana inhibits melanin formation in B16F10 cells by down-regulating the tyrosinase expression (Ryu et al., 2012) . However, the anti-infl ammatory activity of MF has not yet been elucidated. Therefore, in the present study, we evaluated the anti-infl ammatory effects of MF isolated from the seedcases of G. mangostana in LPS-stimulated RAW264.7 macrophages.
MATERIALS AND METHODS

Materials
Mangostenone F (MF, Fig. 1A ) used in the present study was obtained from Dr. Hyung Won Ryu of Korea Research Institute of Bioscience and Biotechnology and dissolved in dimethyl sulfoxide. LPS, a Griess reagent, an NP40 cell lysis buffer, a protease inhibitor cocktail, and a NuCLEAR Extraction Kit were purchased from Sigma-Aldrich (St. Louis, MO, USA). Antibodies for β-Tubulin, IκBα, NF-κB p65, and lamin B were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibody for iNOS was purchased from BD Pharmingen (San Diego, CA, USA). Antibodies for β-actin, ERK, phosphor-ERK (T202/Y204), JNK, phosphor-JNK (T183/ Y185), p38, and phosphor-p38 (Thr180/Tyr182) were purchased from Cell Signaling Technology (Danvers, MA, USA). Goat anti-mouse IgG HRP-conjugated antibody was from SouthernBiotech (Birmingham, AL, USA). Goat anti-rabbit IgG HRP-conjugated antibody, Opti-MEM I medium, and Lipofectamine 2000 were purchased from Invitrogen (Carlsbad, CA, USA). The pNF-κB-Luc and pAP-1-Luc reporter vectors were purchased from Stratagene (La Jolla, CA, USA) and Panomics (Fremont, CA, USA), respectively. The pRL-TK internal control vector was purchased from Promega (Madison, WI, USA). Enzyme-linked immunosorbent assay (ELISA) kits for TNF-α, IL-6, and IL-1β were purchased from R&D Systems (Minneapolis, MN, USA).
Cell culture
RAW264.7 macrophage cells were purchased from American Type Culture Collection (Manassas, VA, USA). The cells were grown in DMEM supplemented with 10% fetal bovine serum (Hyclone, Logan, UT, USA), 100 units/ml of penicillin, and 100 μg/ml of streptomycin (Invitrogen, Carlsbad, CA, USA) in a humidifi ed atmosphere at 37 o C with 5% CO 2 . 
Cytotoxicity assay
Cell viability was measured using an EZ-Cytox cell viability assay kit (DAEIL lab, Seoul, Korea) according to the manufacturer's instruction. RAW264.7 cells were cultured in a 96-well plate at a density of 2×10 5 cells/ml for 20 h. The cells were subsequently treated with different concentrations of MF (0, 10, 20, 40, 60, 80 , and 100 μM). After incubation for 24 h, 10 μl of the kit solution was added to each well and further incubated for 4 h at 37 o C and 5% CO 2 . The index of the cell viability was determined by measuring the formazan production with an ELISA reader (Benchmark Plus, Bio-Rad, Hercules, CA, USA) at an absorbance of 480 nm. The reference wavelength was 650 nm. Cell viability was determined relative to the untreated control cells.
Determination of NO, TNF-α, IL-6, and IL-1β production
RAW264.7 cells were cultured in a 96-well plate at a density of 2×10 5 cells/ml for 24 h. After incubation, the cells were pretreated with different concentrations of MF (20, 40, and 60 μM) for 2 h and were treated with 1 μg/ml of LPS for an additional 18 h. The culture media were collected at the end of the culture period for the NO, TNF-α, IL-6, and IL-1β assays.
For a nitrite assay, the culture media (100 μl) was mixed with an equal volume of Griess reagent (Sigma-Aldrich) in a 96-well plate and then incubated for 15 min at room temperature. The absorbance at 540 nm was measured, and the concentration of nitrite was calculated using a calibration standard curve constructed using sodium nitrite dissolved in DMEM.
The concentrations of TNF-α, IL-6, and IL-1β in culture media were measured using an ELISA kit (R&D Systems) according to the manufacturer's instructions. The results are presented as the mean ± SD of three replicates from one representative experiment.
Total proteins extraction
RAW264.7 cells were cultured in a 100 mm dish at a density of 2×10 5 cells/ml for 24 h. After incubation, the cells were pretreated with different concentrations of MF (20, 40, and 60 μM) for 2 h and were treated with 1 μg/ml of LPS for the indicated times. The cells were harvested and lysed with the NP40 cell lysis buffer in the presence of a protease inhibitor cocktail (Sigma-Aldrich) and PMSF (Sigma-Aldrich). The samples were incubated for 30 min on ice and then centrifuged at 12,000 rpm for 15 min at 4 o C. The cell extracts were collected and stored at -80 o C until used for further studies. The protein contents were determined by a Bio-Rad Protein Assay (BioRad).
Nuclear proteins extraction
RAW264.7 cells were cultured in a 100 mm dish at a density of 2×10 5 cells/ml for 24 h. After incubation, the cells were pretreated with different concentrations of MF (20, 40, and 60 μM) for 2 h and were treated with 1 μg/ml of LPS for 30 min.
The cells were harvested and nuclear and cytosolic fractions were prepared using a NuCLEAR Extraction Kit (Sigma-Aldrich) according to the manufacturer's instruction.
Western blotting
After quantifi cation of the protein contents, equal amounts of protein were resolved on SDS-polyacrylamide gels and then transferred to nitrocellulose membranes (Hybond ECL Nitrocellulose; Amersham Biosciences, Bucks, UK). The membranes were blocked with 5% nonfat dried milk and incubated with the primary antibodies in a 10 ml buffer (Tris-buffered saline and 0.1% Tween 20 with 5% nonfat dried milk) with gentle shaking at 4 o C overnight. After incubation, the membranes were washed, incubated with HRP conjugated secondary antibody for 2 h at room temperature, and then washed again. The blotted proteins were detected using an enhanced chemiluminescence detection system (GE Healthcare, Bucks, UK).
Luciferase assay
RAW264.7 cells were cultured in a 6-well plate at a density of 4×10 5 cells/ml for 24 h. The cells were transfected with a pNF-κB-Luc, a pAP-1-Luc reporter vector, and a pRL-TK internal control vector using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. After transfection, the cells were pretreated with different concentrations of MF (20, 40, and 60 μM) for 2 h and were treated with 1 μg/ml of LPS. After 24 h of stimulation, the cells were then collected, lysed, and luciferase activity was measured using the Dualluciferase Reporter Assay System (Promega) and a luminometer (Berthold Technologies, Bad Wildbad, Germany).
Electrophoretic mobility shift assay (EMSA)
After nuclear extraction, NF-κB DNA binding capacity was determined using an NF-κB EMSA kit (Panomics) according to the manufacturer's instructions. Briefl y, nuclear extracts (6 μg) were mixed with a biotin labeled NF-κB probe and incubated at 37 o C for 30 min. DNA-protein complexes were separated www.biomolther.org in a 6% non-denaturing polyacrylamide gel in a 0.5x TBE buffer at 120 V for 55 min and then transferred to a Biodyne B nylon membrane (Pierce, Rockford, IL, USA) at 300 mA for 30 min. The membrane was fi xed using a UV crosslinker, blocked with a blocking buffer and incubated with a streptavidin-HRP mixture for 15 min at room temperature. After incubation, the membrane was washed and detected using an imaging system (Princeton Instruments, NJ, USA).
Statistical analysis
All data are presented as the mean ± SD. The signifi cance of the differences between the means of the treated and untreated groups was determined through a Student's t test. A p value <0.05 was considered to be signifi cant.
RESULTS
Eff ect of MF on NO production and iNOS expression levels in LPS-stimulated RAW264.7 cells
First, we determined the cell cytotoxicity of MF against RAW264.7 cells. The cells were treated with different concentrations of MF (0, 10, 20, 40, 60, 80, and 100 μM) for 24 h, and the cell cytotoxicity was determined using the EZ-Cytox cell viability assay kit. As shown in Fig. 1B , MF did not exhibit cytotoxicity to RAW264.7 cells up to 80 μM but did inhibit cell viability at doses of 100 μM. To investigate whether MF possess potential anti-infl ammatory effects in LPS-stimulated RAW264.7 cells, we investigated the inhibitory effects of MF on NO production (Fig. 1C) . The levels of NO in the culture media were determined using the Griess reagent. LPS treatment signifi cantly increased the production of NO by approximately 7-fold when compared with the untreated cells (p<0.001). However, the LPS-induced NO production was signifi cantly reduced in the cells pretreated with MF (20, 40, and 60 μM) in a dose-dependent manner. To further examine the cause of reduced NO production by MF, iNOS expression was measured by western blot analysis. As expected, LPS treatment signifi cantly increased the expression of iNOS in RAW264.7 cells. However, the LPS-induced expression of iNOS was reduced by pretreating cells with MF (20, 40, and 60 μM) in a dose-dependent manner (Fig. 1D) . These results suggest that MF decreased the NO production by inhibiting the expression of iNOS.
Eff ect of MF on TNF-α, IL-6, and IL-1β production in LPS-stimulated RAW264.7 cells
To determine the effects of MF on the production of proinfl ammatory cytokines TNF-α, IL-6, and IL-1β, RAW264.7 cells were pretreated with different concentrations of MF (20, 40, and 60 μM) and stimulated with 1 μg/ml of LPS for 16 h. The pro-infl ammatory cytokines (TNF-α, IL-6, and IL-1β) in the culture media were measured using ELISA kits. As shown in Fig. 2 , the levels of TNF-α (p<0.001), IL-6 (p<0.001), and IL-1β (p<0.001) were markedly increased in the LPS-stimulated RAW264.7 cells when compared with the untreated cells. However, the treatment of MF before 2 h LPS treatment markedly decreased the levels of TNF-α (p<0.001), IL-6 (p<0.001), and IL-1β (p<0.001) in a dose-dependent manner.
Eff ect of MF on NF-κB transcriptional and DNA binding activity in LPS-stimulated RAW264.7 cells
To address the mechanism in which MF reduces LPS-induced iNOS expression, we analyzed the NF-κB activation using a luciferase reporter gene assay and an EMSA assay. To investigate the effect of MF on the NF-κB transcriptional activity, RAW264.7 cells were transiently transfected with the pNF-κB-Luc plasmid (containing repeats of NF-κB recognition sequences) and pRL-TK plasmid (containing cDNA encoding Renilla luciferase). As shown in Fig. 3A , the NF-κB reporter MF (20, 40 , and 60 μM) for 1 h and then incubated for 24 h with LPS (1 μg/ml). The NF-κB luciferase activity was determined using a dual-luciferase reporter assay. Error bars represent the mean ± SD. # p<0.001 vs. control, *p<0.01 vs. LPS, **p<0.001 vs. LPS. (B and C) RAW 264.7 cells were pretreated with MF (20, 40, and 60 μM) for 1 h and then incubated for 30 min with LPS (1 μg/ml). The nuclear and cytosolic extracts were prepared and the NF-κB DNA binding activity was analyzed using an EMSA assay (B). The IκB-α degradation and p65 nuclear translocation levels were determined using western blot analysis (C).
http://dx.doi.org/10.4062/biomolther.2014.052 activity was signifi cantly increased in the LPS-treated cells when compared with the untreated cells (p<0.001). However, NF-κB reporter activity was signifi cantly decreased in the cells pretreated with MF in a dose-dependent manner. Moreover, NF-κB DNA binding activity increased in the LPS-treated cells as shown by EMSA. However, MF treatment in the LPS-treated cells dose-dependently decreased the NF-κB DNA binding activity (Fig. 3B) . These results indicated that MF suppressed the production of NO and pro-infl ammatory cytokines through the attenuation of NF-κB DNA binding activity.
Eff ect of MF on degradation of IκB-α and nuclear translocation of p65 in LPS-stimulated RAW264.7 cells
To further investigate the molecular mechanisms of MFmediated inhibition of iNOS expression, we investigated nuclear translocation of p65 subunit of NF-κB and degradation of IκB-α by western blot. As shown in Fig. 3C , LPS treatment signifi cantly increased the nuclear translocation of p65 when compared with the untreated cells. However, MF pretreatment dose-dependently inhibited the nuclear translocation of p65. In addition, LPS treatment markedly induced the degradation of cytosolic IκB-α in RAW264.7 cells. However, this effect was inhibited by MF treatment in a dose-dependent manner. These results strongly suggested that MF prevented the nuclear translocation of NF-κB p65 by blocking the degradation of IκB-α.
Eff ect of MF on AP-1 transcriptional activity and MAPK phosphorylation in LPS-stimulated RAW264.7 cells
To further identify the mechanism through which MF exhibits anti-infl ammatory effects in LPS-stimulated RAW264.7 cells, we assessed the activation of AP-1 by a luciferase reporter gene assay. RAW264.7 cells were transiently transfected with the pAP-1-Luc plasmid and pRL-TK plasmid. As shown in Fig. 4A , LPS treatment signifi cantly increased the AP-1 reporter activity when compared with the untreated cells (p<0.001). However, MF treatment signifi cantly decreased the LPS-induced AP-1 reporter activity in a dose-dependent manner. To further clarify the molecular mechanism of the antiinfl ammatory effects of MF, we examined the phosphorylation of ERK, JNK, and p38 MAPK using a western blot analysis. LPS treatment signifi cantly increased the phosphorylation of ERK, JNK, p38. However, MF treatment reduced phosphorylated ERK, JNK, p38 levels in LPS-stimulated RAW264.7 cells in a dose-dependent manner (Fig. 4B) . These results suggest that the inhibitory effect of MF on LPS-induced infl ammation might be involved in MAPK signaling pathway.
DISCUSSION
The objective of the present study was to evaluate the antiinfl ammatory effects of MF isolated from the seedcases of G. mangostana in LPS-stimulated RAW264.7 macrophages. In this study, we showed that MF inhibited MAP kinases, AP-1 and NF-κB activation, and the subsequent induction of proinfl ammatory mediators such as NO, iNOS, TNF-α, IL-6, and IL-1β.
In response to LPS stimulation, macrophages produce proinfl ammatory mediators such as NO and several cytokines such as TNF-α, IL-6, and IL-1β (Reddy and Reddanna, 2009 ). LPS-induced NO production is mediated by iNOS expre ssion. Excessive cytokines and iNOS-mediated NO production has www.biomolther.org been linked with many pathophysiological conditions such as infl ammation and tumorigenesis (Pan et al., 2009) . A previous report revealed that 1,5-anhydro-D-fructose attenuates LPSinduced iNOS expression and NO production in RAW264.7 cells (Meng et al., 2009) . Consistent with this previous report, our results demonstrated that MF inhibited the LPSinduced NO production and decreased the iNOS expression in RAW264.7 cells. TNF-α and IL-6 have been implicated in autoimmune diseases including rheumatoid arthritis. It is also known that IL-1β is associated with the nociceptive activity of certain stimulating factors such as zymosan and acetic acid (Wang et al., 2012) . Many researches have shown that phytochemicals such as schisantherin A (Ci et al., 2010) , stevioside (Fengyang et al., 2012) , and sophorafl avanone G (Wun et al., 2013) suppress pro-infl ammatory cytokines such as TNF-α, IL-6, and IL-1β in LPS-stimulated RAW264.7 cells. In addition, Lee et al. (2012) documented that 3,4,5-trihydroxycinnamic acid inhibits LPS-induced production of NO, TNF-α, and IL-1β in BV2 microglial cells. Consistent with previous reports, we showed that MF suppresses the LPS-induced production of TNF-α, IL-6, and IL-1β in RAW264.7 cells. Therefore, our fi ndings suggest that MF has an anti-infl ammatory effect that may inhibit iNOS-mediated NO production, as well as TNF-α, IL-6, and IL-1β production.
It is known that NF-κB plays an important role in various pathological conditions as a transcription factor for pro-infl ammatory mediators such as iNOS, TNF-α, and IL-1β . In response to LPS stimulation, NF-κB is translocated into a nucleus through IκB degradation by activating TLR4-mediated MyD88-dependent signaling pathway and in turn induces pro-infl ammatory mediators (Kawai and Akira, 2006) . Many studies have reported that the suppression of NF-κB activation by phytochemicals inhibits the increase of pro-infl ammatory mediators such as iNOS, TNF-α, IL-6, and IL-1β in LPS-stimulated RAW264.7 cells (Gao et al., 2012; Han et al., 2012; . In the present study, we showed that MF signifi cantly attenuated LPS-induced IκB degradation and nuclear translocation of p65 in LPS-stimulated RAW264.7 cells. Moreover, MF signifi cantly decreased the NF-κB luciferase and DNA binding activities in LPS-stimulated RAW264.7 cells. These fi ndings suggest that MF may indicate an antiinfl ammatory activity by inhibiting NF-κB activation.
In addition to NF-κB, MAPK including p38, ERK, and JNK plays an important role in cytokines production as well as cell growth and differentiation (Han et al., 2010) . Upon stimulation with LPS, the phosphorylation of MAPK is involved in the activation of transcription factors including AP-1, CREB, STAT1, and NF-κB, and subsequently produces cytokines (Han et al., 2010; Choi et al., 2012; Wang et al., 2012) . Previous reports have revealed that pro-infl ammatory mediators are regulated by the down-regulation of MAPK, NF-κB, and AP-1 in LPStreated RAW264.7 cells Su et al., 2011) . In agreement with previous reports, the present study showed that MF diminished the phosphorylation of p38, ERK, and JNK, and reduced the activation of AP-1 and NF-κB in LPS-stimulated RAW264.7 cells. To the best of our knowledge, MF is the anti-infl ammatory natural compound that down-regulates LPS-induced MAPK, NF-κB, and AP-1 signaling pathways.
In conclusion, the present study demonstrates that MF isolated from G. mangostana suppresses the production of NO, iNOS, and pro-infl ammatory cytokines (TNF-α, IL-6, and IL-1β) in LPS-stimulated RAW264.7 macrophages. Furthermore, our results show that these effects of MF are related to the inhibition of MAPK, NF-κB, and AP-1 activation in LPS-stimulated RAW264.7 macrophages. This report indicates for the fi rst time that MF exhibits the anti-infl ammatory effect, suggesting that MF should be considered as a candidate potential anti-infl ammatory agent for the treatment of infl ammatory diseases. Therefore, further studies are necessary to clearly elucidate the exact mechanisms and clinical therapeutic potential of MF.
